scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1042/BST0311413 |
P698 | PubMed publication ID | 14641077 |
P50 | author | Tom Metz | Q42666092 |
P2093 | author name string | Baynes JW | |
Thorpe SR | |||
Alderson NL | |||
Januszewski AS | |||
Metz TO | |||
P433 | issue | Pt 6 | |
P921 | main subject | lipid | Q11367 |
P304 | page(s) | 1413-1416 | |
P577 | publication date | 2003-12-01 | |
P1433 | published in | Biochemical Society Transactions | Q864226 |
P1476 | title | Role of lipids in chemical modification of proteins and development of complications in diabetes | |
P478 | volume | 31 |
Q46641374 | A method to produce fully characterized ubiquitin covalently modified by 4-hydroxy-nonenal, glyoxal, methylglyoxal, and malondialdehyde |
Q37930514 | Advanced glycation end products and diabetic retinopathy |
Q40346041 | Amelioration of oxidant stress by the defensin lysozyme |
Q40802125 | Below the radar: advanced glycation end products that detour "around the side". Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes? |
Q46498811 | Design, synthesis, ADME properties, and pharmacological activities of β-alanyl-D-histidine (D-carnosine) prodrugs with improved bioavailability |
Q37486465 | Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions |
Q34321561 | Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosis |
Q37733102 | Dietary hyperglycemia, glycemic index and metabolic retinal diseases |
Q34399952 | Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice |
Q45016977 | Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat. |
Q36082148 | Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications |
Q43117950 | Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina |
Q34352853 | Multiplex analysis of age-related protein and lipid modifications in human Bruch's membrane |
Q35644521 | Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy |
Q38473579 | Oxidation as an important factor of protein damage: Implications for Maillard reaction. |
Q46272669 | Oxidative stress and antioxidant status in patients with late-onset gestational diabetes mellitus |
Q34569271 | Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia |
Q36891939 | Oxidative stress, AGE, and atherosclerosis |
Q46613203 | Plasma low-molecular weight fluorescence in type 1 diabetes mellitus. |
Q36204035 | Post-Amadori AGE inhibition as a therapeutic target for diabetic complications: a rational approach to second-generation Amadorin design |
Q46428511 | Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors |
Q35221896 | Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme. |
Q46613239 | Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats |
Q45918596 | Resorcylidene aminoguanidine induces antithrombotic action that is not dependent on its antiglycation activity. |
Q40394758 | Role of glucoxidation and lipid oxidation in the development of atherosclerosis. |
Q42951001 | Skin and urine pentosidine weakly correlate with joint damage in a cohort of patients with early signs of osteoarthritis (CHECK) |
Q36625195 | The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes |
Q37801857 | The pathogenic role of Maillard reaction in the aging eye. |
Search more.